Background Background For decades there has
For decades there has been interest in the possibility that people been interest in the possibility that people with schizophrenia might have some with schizophrenia might have some protection against cancer, and that, if this protection against cancer, and that, if this were so, it might hold clues about were so, it might hold clues about aetiological mechanisms in schizophrenia. aetiological mechanisms in schizophrenia.
Aims Aims To study cancer incidence in
To study cancer incidence in schizophrenia. schizophrenia.
Method Method Cohort analysis of linked
Cohort analysis of linked hospital and death records was used to hospital and death records was used to compare cancer rates in people with compare cancer rates in people with schizophrenia with a reference cohort. schizophrenia with a reference cohort.
Results

Results We did not find a reduced risk
We did not find a reduced risk for cancer overall (rate ratio 0.99, 95% CI for cancer overall (rate ratio 0.99,95% CI 0.90^1.08) or for most individual cancers. 0.90^1.08) or for most individual cancers. There was, however, a significantly low There was, however, a significantly low rate ratio for skin cancer (0.56,95% CI rate ratio for skin cancer (0.56,95% CI 0.36^0.83). 0.36^0.83).
Conclusions Conclusions We found no evidence
We found no evidence that schizophrenia confers protection that schizophrenia confers protection against cancer in general.Low rates of skin against cancer in general.Low rates of skin cancer are consistent with the hypothesis cancer are consistent with the hypothesis that sun exposure may influence the that sun exposure may influence the development of schizophrenia, although development of schizophrenia, although other explanations are also possible. other explanations are also possible.
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For nearly a century there has been interest For nearly a century there has been interest in the possibility that people with schizoin the possibility that people with schizophrenia have a lower risk of cancer than phrenia have a lower risk of cancer than the general population, with speculation the general population, with speculation that lower susceptibility to cancer might that lower susceptibility to cancer might provide clues about the biological basis of provide clues about the biological basis of schizophrenia. Recently, several biological schizophrenia. Recently, several biological hypotheses have been proposed to explain hypotheses have been proposed to explain why people with schizophrenia might be why people with schizophrenia might be protected against cancer, including a proprotected against cancer, including a protective effect of excess dopamine (Basu & tective effect of excess dopamine , enhanced natural killer , enhanced natural killer cell activity (Yovel cell activity (Yovel et al et al, 2000) , an increase , 2000), an increase in the rate of apoptosis (Catts & Catts, in the rate of apoptosis and modulation by antipsychotic 2000) and modulation by antipsychotic drugs of the human cytochrome enzymes drugs of the human cytochrome enzymes involved in mutagen activation and involved in mutagen activation and elimination . elimination . However, the epidemiological evidence for However, the epidemiological evidence for protection is not convincing. We therefore protection is not convincing. We therefore used population-based data from a health used population-based data from a health region in the southern part of England to region in the southern part of England to study the occurrence of cancer in people study the occurrence of cancer in people with schizophrenia. with schizophrenia.
METHOD METHOD Population and data Population and data
We used data from the Oxford Record We used data from the Oxford Record Linkage Study (Goldacre Linkage Study (Goldacre et al et al, 2000) . . This data-set includes brief statistical abstracts data-set includes brief statistical abstracts of records of all hospital admissions (inof records of all hospital admissions (including day cases) in National Health cluding day cases) in National Health Service (NHS) hospitals, and all deaths reService (NHS) hospitals, and all deaths regardless of where they occurred, in defined gardless of where they occurred, in defined populations within the former Oxford NHS populations within the former Oxford NHS Region from 1 January 1963 to 31 March Region from 1 January 1963 to 31 March 1999. Until 1994 the data-set also included 1999. Until 1994 the data-set also included all contacts with specialist psychiatric serall contacts with specialist psychiatric services in the health district of Oxfordshire, vices in the health district of Oxfordshire, including out-patients as well as day cases including out-patients as well as day cases and in-patients. The hospital data were and in-patients. The hospital data were collected routinely in the NHS as part of collected routinely in the NHS as part of the region's hospital statistics system. The the region's hospital statistics system. The death data derive from death certificates. death data derive from death certificates. Data collection, including those for psyData collection, including those for psychiatry, covered part of one health district chiatry, covered part of one health district and its associated hospitals from 1963 and its associated hospitals from 1963 (population 350 000), two districts includ-(population 350 000), two districts including Oxfordshire from 1966 (population ing Oxfordshire from 1966 (population 850 000), six districts from 1975 (popu-850 000), six districts from 1975 (population 1.9 million) and all of the region's lation 1.9 million) and all of the region's districts from 1987 (population 2.5 districts from 1987 (population 2.5 million). The data for each individual were million). The data for each individual were linked together, as they accrued, as part of linked together, as they accrued, as part of the region's health information system. the region's health information system. They are now anonymised and archived. They are now anonymised and archived.
The schizophrenia cohort was conThe schizophrenia cohort was constructed by identifying the first admission structed by identifying the first admission to an NHS hospital during the study period, to an NHS hospital during the study period, or the first contact with specialist psychior the first contact with specialist psychiatric services for those in Oxfordshire, for atric services for those in Oxfordshire, for each individual with the condition. A refereach individual with the condition. A reference cohort was constructed by identifying ence cohort was constructed by identifying the first admission for each individual with the first admission for each individual with various medical and surgical conditions (see various medical and surgical conditions (see footnotes to Table 2 ). This is based on our footnotes to Table 2 ). This is based on our 'reference' group of conditions, which has 'reference' group of conditions, which has been used in other studies of interrelationbeen used in other studies of interrelationships between diseases (Goldacre ships between diseases (Goldacre et al et al, , 2000) . We searched the database for any 2000). We searched the database for any subsequent NHS hospital care for, or death subsequent NHS hospital care for, or death from, cancers in these two cohorts. We confrom, cancers in these two cohorts. We considered that rates of cancer in the reference sidered that rates of cancer in the reference cohort would approximate those in the cohort would approximate those in the general population of the region while general population of the region while allowing for migration in and out of it (data allowing for migration in and out of it (data on migration of individuals were not on migration of individuals were not available). available).
Statistical methods Statistical methods
We calculated rates of each cancer based on We calculated rates of each cancer based on person-years at risk. We took 'date of entry' person-years at risk. We took 'date of entry' into each cohort as the date of first admisinto each cohort as the date of first admission for schizophrenia or reference condision for schizophrenia or reference condition, and 'date of exit' for the analysis of tion, and 'date of exit' for the analysis of each individual cancer as the date of first each individual cancer as the date of first record of the cancer, death or 31 March record of the cancer, death or 31 March 1999, whichever was the earliest. In com-1999, whichever was the earliest. In comparing the schizophrenia cohort with the paring the schizophrenia cohort with the reference cohort, we first calculated rates reference cohort, we first calculated rates for each cancer, standardised by age (in 5-for each cancer, standardised by age (in 5-year age groups), gender, calendar year of year age groups), gender, calendar year of first recorded admission and district of resifirst recorded admission and district of residence, taking the combined schizophrenia dence, taking the combined schizophrenia and reference cohorts as the standard popuand reference cohorts as the standard population. We then applied the overall rates to lation. We then applied the overall rates to the age structure of the individual cohorts the age structure of the individual cohorts of people with schizophrenia or with the of people with schizophrenia or with the reference conditions. We calculated the reference conditions. We calculated the ratio of the standardised rate of occurrence ratio of the standardised rate of occurrence of cancer in the schizophrenia cohort of cancer in the schizophrenia cohort relative to that in the reference cohort. relative to that in the reference cohort. The confidence interval for the rate ratio The confidence interval for the rate ratio and and w w 2 2 statistics for its significance were statistics for its significance were calculated as described elsewhere (Breslow calculated as described elsewhere . . We studied the results for each condiWe studied the results for each condition in the reference cohort separately, as tion in the reference cohort separately, as well as in combination, to ensure that no well as in combination, to ensure that no individual condition disproportionately individual condition disproportionately influenced the 'expected' number of people influenced the 'expected' number of people with subsequent cancer. The people in the with subsequent cancer. The people in the reference cohort who underwent appendireference cohort who underwent appendicectomy or an operation for inguinal hernia cectomy or an operation for inguinal hernia or haemorrhoids showed significantly high or haemorrhoids showed significantly high subsequent admission rates for colorectal subsequent admission rates for colorectal cancers. We therefore excluded these condicancers. We therefore excluded these conditions from the reference cohort in the study tions from the reference cohort in the study of colorectal cancers, when comparing the of colorectal cancers, when comparing the schizophrenia and reference cohorts. schizophrenia and reference cohorts.
RESULTS RESULTS
There were 9649 individuals in the schizoThere were 9649 individuals in the schizophrenia cohort and nearly 600 000 in the phrenia cohort and nearly 600 000 in the comparison cohort. Table 1 shows the age comparison cohort. Table 1 shows the age distribution of patients in the schizophrenia distribution of patients in the schizophrenia cohort at the time of first recorded admiscohort at the time of first recorded admission. Some patients would already have sion. Some patients would already have been quite elderly by the time that data been quite elderly by the time that data collection commenced and others would collection commenced and others would have been in long-term care. The mean have been in long-term care. The mean age at first recorded admission for schizoage at first recorded admission for schizophrenia was 40 years and the modal age phrenia was 40 years and the modal age group was 25-29 years. The average length group was 25-29 years. The average length of follow-up was 12.6 years. of follow-up was 12.6 years.
The risk ratio for cancer, overall, in The risk ratio for cancer, overall, in people with schizophrenia, compared with people with schizophrenia, compared with the reference cohort, was 0.99 (Table 2) . the reference cohort, was 0.99 ( Table 2) . The risk ratio for cancer of the lung was The risk ratio for cancer of the lung was non-significantly raised at 1.18 and that non-significantly raised at 1.18 and that for cancer of the oesophagus was signififor cancer of the oesophagus was significantly raised at 1.61 . No other individual cantly raised at 1.61. No other individual cancer was found to be significantly more cancer was found to be significantly more 3 3 5 3 3 5 AUTHOR'S PROOF AUTHOR'S PROOF common in people with schizophrenia than common in people with schizophrenia than in the reference cohort. Skin cancer was in the reference cohort. Skin cancer was significantly less common in people with significantly less common in people with schizophrenia than in others (Table 2) . schizophrenia than in others ( Table 2 ). The rate ratio for skin cancer was 0.56 The rate ratio for skin cancer was 0.56 ( (P P¼0.004). Malignant melanoma and other 0.004). Malignant melanoma and other skin cancers were, individually, less comskin cancers were, individually, less common in people with schizophrenia than in mon in people with schizophrenia than in the reference cohort. The rate ratio for the reference cohort. The rate ratio for malignant melanoma was particularly low malignant melanoma was particularly low at 0.20 ( at 0.20 (P P¼0.02). Cancer of the rectum 0.02). Cancer of the rectum was significantly lower in the schizophrenia was significantly lower in the schizophrenia cohort than in the comparison cohort, with cohort than in the comparison cohort, with a rate ratio of 0.57 (Table 2 ; a rate ratio of 0.57 (Table 2 ; P P¼0.03). 0.03). Cancer of the colon was lower in the Cancer of the colon was lower in the schizophrenia cohort than in the comparison schizophrenia cohort than in the comparison cohort, but the result was not significant cohort, but the result was not significant (rate ratio 0.72, (rate ratio 0.72, P P¼0.06). 0.06). The results presented here included The results presented here included patients of all ages when they had their first patients of all ages when they had their first recorded admission for schizophrenia. We recorded admission for schizophrenia. We also analysed the data restricting the also analysed the data restricting the analyses to people whose first recorded adanalyses to people whose first recorded admission for schizophrenia (or reference conmission for schizophrenia (or reference condition) was between the ages of 15 years dition) was between the ages of 15 years and 64 years, reasoning that the identificaand 64 years, reasoning that the identification of schizophrenia and of cancers is less tion of schizophrenia and of cancers is less likely to be reliable in the elderly than in likely to be reliable in the elderly than in the younger population. Apart from lowerthe younger population. Apart from lowering statistical power, restriction of the age ing statistical power, restriction of the age range in this way made range in this way made no appreciable no appreciable difference to the results. difference to the results.
DISCUSSION DISCUSSION
Background Background
In 1909 the Commissioners in Lunacy for In 1909 the Commissioners in Lunacy for England and Wales wrote that cancer England and Wales wrote that cancer mortality might be relatively low 'among mortality might be relatively low 'among the insane' and that, if this were proved, it the insane' and that, if this were proved, it might 'have a bearing on its obscure might 'have a bearing on its obscure etiology' (Commissioners in Lunacy for etiology' (Commissioners in Lunacy for England and Wales, 1909) . In that report, England and Wales, 1909) . In that report, proportional mortality ratios were used to proportional mortality ratios were used to compare the death rates of those 'dwelling compare the death rates of those 'dwelling in insane asylums' with those of the general in insane asylums' with those of the general population. This was the basis for their population. This was the basis for their suggestion that 'the insane' might be prosuggestion that 'the insane' might be protected against cancer. Subsequent proportected against cancer. Subsequent proportional mortality studies of individuals with tional mortality studies of individuals with schizophrenia supported this suggestion schizophrenia supported this suggestion (reviewed by Scheflen, 1951) . However, (reviewed by Scheflen, 1951) . However, proportional mortality rates can be misproportional mortality rates can be misleading. People with schizophrenia have leading. People with schizophrenia have high mortality rates for other, non-cancer, high mortality rates for other, non-cancer, causes of death and, in particular, high causes of death and, in particular, high mortality rates for unnatural causes of mortality rates for unnatural causes of death (Herrman death (Herrman et al et al, 1983; Mortensen & , 1983; Mortensen & Juel, 1993) . Accordingly, mortality rates Juel, 1993). Accordingly, mortality rates for cancer, expressed as proportions of all for cancer, expressed as proportions of all causes of death, are low because death rates causes of death, are low because death rates from other causes are high in people with from other causes are high in people with schizophrenia. This point was made eleschizophrenia. This point was made elegantly in the review of schizophrenia and gantly in the review of schizophrenia and cancer by Scheflen (1951) . cancer by Scheflen (1951) . Nonetheless, interest in the possible Nonetheless, interest in the possible protective effect of schizophrenia persisted. protective effect of schizophrenia persisted. The following three decades yielded a large The following three decades yielded a large number of studies (reviewed by Baldwin, number of studies (reviewed by , generally of low statistical power, 1979), generally of low statistical power, and further studies were published after and further studies were published after Baldwin's review. For example, Craig & Baldwin's review. For example, reported that the risk of lung reported that the risk of lung cancer in people with schizophrenia may cancer in people with schizophrenia may be low, despite the fact that high rates of be low, despite the fact that high rates of smoking are well documented in patients smoking are well documented in patients with the latter disorder (Kelly & with the latter disorder (Kelly & McCreadie, 1999) . Two large-scale, longMcCreadie, 1999). Two large-scale, longterm studies in Denmark showed lower term studies in Denmark showed lower rates of several cancers, including lung rates of several cancers, including lung cancer, in people with schizophrenia than cancer, in people with schizophrenia than in the general population (Mortensen, in the general population (Mortensen, 1989 (Mortensen, , 1994 ). The first study followed a 1989, 1994). The first study followed a cohort of 6168 people with schizophrenia cohort of 6168 people with schizophrenia over a period of 27 years -by far the most over a period of 27 years -by far the most substantial piece of work on this topic to substantial piece of work on this topic to date. It found a significantly reduced incidate. It found a significantly reduced incidence of cancer overall in male patients as dence of cancer overall in male patients as well as significant reductions in lung cancer well as significant reductions in lung cancer and some other smoking-related cancers in and some other smoking-related cancers in both men and women (Mortensen, 1989) . both men and women (Mortensen, 1989) . It found a small but significant elevation It found a small but significant elevation in the risk of breast cancer (rate in the risk of breast cancer (rate ratio ratio¼1.19). The results were ascribed to 1.19). The results were ascribed to the hospital environment experienced by the hospital environment experienced by psychiatric patients during the 1950s and psychiatric patients during the 1950s and 1960s when, it was reported, smoking in 1960s when, it was reported, smoking in the study population was said to have been the study population was said to have been restricted both by the patients' limited restricted both by the patients' limited means and by regulations against smoking means and by regulations against smoking in Danish psychiatric hospitals (Mortensen, in Danish psychiatric hospitals (Mortensen, 1989) . It was considered that a low 1989). It was considered that a low pregnancy rate and reduced sexual activity pregnancy rate and reduced sexual activity could have accounted respectively for could have accounted respectively for the increased risk of breast cancer and the the increased risk of breast cancer and the finding of a non-significant reduced risk finding of a non-significant reduced risk of cervical cancer among the female of cervical cancer among the female patients with schizophrenia (Mortensen, patients with schizophrenia (Mortensen, 1989 (Mortensen, ). 1989 .
A more recent, but less statistically A more recent, but less statistically powerful, cohort study was performed in powerful, cohort study was performed in Denmark to determine whether the earlier Denmark to determine whether the earlier findings in an institutional environment, findings in an institutional environment, with restricted access to tobacco, were with restricted access to tobacco, were replicated in a more modern population of replicated in a more modern population of patients (Mortensen, 1994) . The risk patients (Mortensen, 1994) . The risk estimates generated by this study were less estimates generated by this study were less stable, since fewer malignancies were stable, since fewer malignancies were observed in the population. As before, observed in the population. As before, cancer incidence overall was reduced in cancer incidence overall was reduced in male patients. There was a non-significant male patients. There was a non-significant reduction in lung cancer in men, based on reduction in lung cancer in men, based on six cases. The author concluded that the resix cases. The author concluded that the results of this second study did replicate those sults of this second study did replicate those of the first and suggested that neuroleptic of the first and suggested that neuroleptic treatment might somehow be protective treatment might somehow be protective against cancer in people with schizophrenia against cancer in people with schizophrenia (Mortensen, 1994) . (Mortensen, 1994) .
Findings in our study Findings in our study
Our findings do not support the hypothesis Our findings do not support the hypothesis that people with schizophrenia have a that people with schizophrenia have a different overall risk of cancer from that different overall risk of cancer from that of the general population. of the general population.
Cancers of the lung and oesophagus Cancers of the lung and oesophagus
We did not find that lung cancer occurred We did not find that lung cancer occurred less often in people with schizophrenia than less often in people with schizophrenia than in the general population. We found that the in the general population. We found that the risk of lung cancer was non-significantly risk of lung cancer was non-significantly elevated and that the risk of cancer of the elevated and that the risk of cancer of the oesophagus was significantly elevated in oesophagus was significantly elevated in people with schizophrenia, compared with people with schizophrenia, compared with the reference cohort. Smoking is the major the reference cohort. Smoking is the major risk factor for lung cancer and a high level risk factor for lung cancer and a high level of alcohol consumption is a risk factor for of alcohol consumption is a risk factor for cancer of the oesophagus. The elevated cancer of the oesophagus. The elevated rates of cancer of the lung and oesophagus rates of cancer of the lung and oesophagus may be attributable to smoking and alcohol may be attributable to smoking and alcohol consumption in the population with schizoconsumption in the population with schizophrenia. We do not have data on smoking phrenia. We do not have data on smoking history or alcohol consumption. The rehistory or alcohol consumption. The research literature shows that people with search literature shows that people with schizophrenia are more likely to smoke schizophrenia are more likely to smoke than the general population (Kelly & than the general population (Kelly & McCreadie, 1999) . If there were much McCreadie, 1999) . If there were much higher rates of smoking in the population higher rates of smoking in the population with schizophrenia studied by us, we might with schizophrenia studied by us, we might have expected to see higher rates of lung have expected to see higher rates of lung cancer in these patients than we did. Thus, cancer in these patients than we did. Thus, we cannot rule out the possibility that we cannot rule out the possibility that schizophrenia does protect against lung schizophrenia does protect against lung cancer to some extent. Nonetheless, becancer to some extent. Nonetheless, because lung cancer rates in the schizophrenia cause lung cancer rates in the schizophrenia cohort were high, our results indicate that it cohort were high, our results indicate that it is unlikely that schizophrenia is associated is unlikely that schizophrenia is associated with a major protective effect against lung with a major protective effect against lung cancer, and our results show no evidence cancer, and our results show no evidence of a general protective effect against other of a general protective effect against other cancers. cancers.
Breast cancer Breast cancer
We found no elevation of breast cancer in We found no elevation of breast cancer in our schizophrenia cohort, with a rate ratio our schizophrenia cohort, with a rate ratio of 1. of 1.
S C HI ZOP H R E NI A A ND C A NC E R S CHI ZOP HR E NI A AND C ANC E R
Colorectal cancer Colorectal cancer
We found a significantly low rate of rectal We found a significantly low rate of rectal cancer. Dietary factors have a role in the cancer. Dietary factors have a role in the aetiology of colo aetiology of colorectal cancer, and there is rectal cancer, and there is evidence that there evidence that there are differences in diet are differences in diet between people with schizophrenia and between people with schizophrenia and others (McCreadie, 2003) , but a specific others (McCreadie, 2003) , but a specific lowering of the risk of colorectal cancer is lowering of the risk of colorectal cancer is not a consistent feature not a consistent feature of the literature on of the literature on schizophrenia and cancer. schizophrenia and cancer.
Brain tumours Brain tumours
There was no elevation of rates of brain There was no elevation of rates of brain tumours after a first diagnosis of schizotumours after a first diagnosis of schizophrenia. This shows that there was no phrenia. This shows that there was no evidence of any significant misdiagnosis of evidence of any significant misdiagnosis of brain tumours as schizophrenia. brain tumours as schizophrenia.
Skin cancer Skin cancer
We found that skin cancer occurred considWe found that skin cancer occurred considerably less frequently in patients with erably less frequently in patients with schizophrenia than in the general popuschizophrenia than in the general population. There is not much published inforlation. There is not much published information about schizophrenia and skin mation about schizophrenia and skin cancer. However, a similar finding was cancer. However, a similar finding was reported from the second Danish recordreported from the second Danish recordlinkage study (Mortensen, 1994) . The rate linkage study (Mortensen, 1994) . The rate ratio in that study for malignant melanoma ratio in that study for malignant melanoma in people with schizophrenia, 0.14, was in people with schizophrenia, 0.14, was similar to our ratio of 0.20. Mortensen similar to our ratio of 0.20. Mortensen (1994) also reported a reduction in other (1994) also reported a reduction in other skin cancers, similar to our risk estimate. skin cancers, similar to our risk estimate. There are several reasons why skin cancer There are several reasons why skin cancer rates may be lower than expected in people rates may be lower than expected in people with schizophrenia. People with schizowith schizophrenia. People with schizophrenia may spend less time in the sun than phrenia may spend less time in the sun than the general population. They may be less the general population. They may be less likely to seek medical advice than others. likely to seek medical advice than others. If doctors are less inclined to treat skin If doctors are less inclined to treat skin cancer in people with schizophrenia than cancer in people with schizophrenia than in others, people with schizophrenia and in others, people with schizophrenia and skin cancer might be less likely to be skin cancer might be less likely to be admitted to hospital and therefore be selecadmitted to hospital and therefore be selectively missed by our study method. Another tively missed by our study method. Another possible explanation is that our findings possible explanation is that our findings might be due to chance: because we anamight be due to chance: because we analysed 32 cancers, we would expect to find lysed 32 cancers, we would expect to find one or two statistically significant results one or two statistically significant results by chance alone. However, with a prior by chance alone. However, with a prior hypothesis from the Danish record-linkage hypothesis from the Danish record-linkage study that a low rate of skin cancer might study that a low rate of skin cancer might be expected (Mortensen, 1994) , and a sigbe expected (Mortensen, 1994) , and a significance level of 1 in 250 ( nificance level of 1 in 250 (P P¼0.004) in 0.004) in our study, we are reluctant to accept chance our study, we are reluctant to accept chance as the most likely explanation. The low as the most likely explanation. The low level of skin cancer is consistent with the level of skin cancer is consistent with the hypothesis hypothesis that sun exposure, perhaps that sun exposure et al, 1999), that could , 1999) , that could be used to determine whether the deficit be used to determine whether the deficit of skin cancer in people with schizophrenia of skin cancer in people with schizophrenia is a consistent finding. The methods used by is a consistent finding. The methods used by van der Mei van der Mei et al et al (2003) , who made physi- (2003), who made physical measurements of evidence of past skin cal measurements of evidence of past skin exposure to solar radiation in people exposure to solar radiation in people with multiple sclerosis, could be used to with multiple sclerosis, could be used to study the skin structure of people with study the skin structure of people with and without schizophrenia. and without schizophrenia.
Strengths and weaknesses
Strengths and weaknesses of the study of the study
The strengths of the study are that it The strengths of the study are that it provides information on large numbers of provides information on large numbers of people in the schizophrenia cohort; and people in the schizophrenia cohort; and that, for the common cancers studied, there that, for the common cancers studied, there are large numbers of people with cancer are large numbers of people with cancer in the cohort. The study design also has in the cohort. The study design also has We found a deficit of skin cancer. A protective effect of solar radiation, perhaps mediated through vitamin D metabolism, in the development of schizophrenia is one mediated through vitamin D metabolism, in the development of schizophrenia is one possible explanation. A tendency of people with schizophrenia to avoid exposure to possible explanation. A tendency of people with schizophrenia to avoid exposure to sunshine is another possibility. sunshine is another possibility.
LIMITATIONS LIMITATIONS
& & The data-set was confined to people in contact with specialist hospital services.
The data-set was confined to people in contact with specialist hospital services.
& & The cohorts were based on prevalent cases^the first recorded admission or The cohorts were based on prevalent cases^the first recorded admission or day-case care for each person with each condition in the period covered by the day-case care for each person with each condition in the period covered by the data-set^rather than on incident cases. data-set^rather than on incident cases.
& & There was no information on behavioural factors such as smoking, diet or sun There was no information on behavioural factors such as smoking, diet or sun exposure. exposure.
weaknesses. The database does not contain weaknesses. The database does not contain information on potential confounding or information on potential confounding or explanatory factors, in particular smoking, explanatory factors, in particular smoking, alcohol, diet and sun exposure. The dataalcohol, diet and sun exposure. The database misses diseases that occurred in people base misses diseases that occurred in people who were not admitted to hospital, or who who were not admitted to hospital, or who were admitted to a hospital outside its were admitted to a hospital outside its coverage, or who were admitted to hospital coverage, or who were admitted to hospital outside the period covered by the study. We outside the period covered by the study. We have no information on the criteria used for have no information on the criteria used for the diagnosis of schizophrenia, other than the diagnosis of schizophrenia, other than the fact of its having been recorded as the the fact of its having been recorded as the clinical diagnosis on a hospital record. clinical diagnosis on a hospital record. Although the diagnosis may sometimes be Although the diagnosis may sometimes be unreliable, it seems unlikely that its unreliaunreliable, it seems unlikely that its unreliability would be related to patients' risk of bility would be related to patients' risk of subsequent cancer. Accordingly, we think subsequent cancer. Accordingly, we think that diagnostic unreliability in some cases that diagnostic unreliability in some cases is unlikely either to create false associations is unlikely either to create false associations with cancer or to mask completely any real with cancer or to mask completely any real associations. It is possible that important associations. It is possible that important life-threatening diseases such as cancer are life-threatening diseases such as cancer are underdiagnosed, or undertreated, in people underdiagnosed, or undertreated, in people with schizophrenia. It is also theoretically with schizophrenia. It is also theoretically possible that incidence rates for cancer possible that incidence rates for cancer could be underenumerated in schizophrenia could be underenumerated in schizophrenia because of competing causes of mortalitybecause of competing causes of mortalityfor example, if undiagnosed cancers are for example, if undiagnosed cancers are 'overtaken' by deaths from other causes 'overtaken' by deaths from other causes such as accidents. However, the fact that such as accidents. However, the fact that the overall rate ratio for cancer in our study the overall rate ratio for cancer in our study is so close to 1 (Table 2) suggests that these is so close to 1 (Table 2) suggests that these are probably not major factors in the are probably not major factors in the interpretation of our results. If they were, interpretation of our results. If they were, any real excess or deficit of cancers in the any real excess or deficit of cancers in the schizophrenia cohort would have to be preschizophrenia cohort would have to be precisely balanced by unidentified biases bringcisely balanced by unidentified biases bringing the rate ratio back to 1. This seems ing the rate ratio back to 1. This seems unlikely. unlikely.
Implications of our findings Implications of our findings
In conclusion, our data suggest that people In conclusion, our data suggest that people with schizophrenia are not protected with schizophrenia are not protected against cancer in general. There is no eviagainst cancer in general. There is no evidence of increased susceptibility to breast dence of increased susceptibility to breast cancer. There is evidence that the risk of cancer. There is evidence that the risk of skin cancer may be low. As we are unable skin cancer may be low. As we are unable to take important lifestyle factors into acto take important lifestyle factors into account, such as smoking and exposure to socount, such as smoking and exposure to solar radiation, our results should be regarded lar radiation, our results should be regarded as suggestive rather than definitive. as suggestive rather than definitive.
